Skip to main content
. 2010 Jun 1;54(8):3255–3261. doi: 10.1128/AAC.00397-10

FIG. 4.

FIG. 4.

In vivo efficacy of NITD203. AG129 mice were intraperitoneally inoculated with 2 × 106 PFU of DENV-2 (strain TSV01) on day 0. The infected mice (6 or 8 animals per group) were immediately treated with the indicated doses of NITD203 orally twice per day for three consecutive days. The peak viremia on day 4 postinfection was quantified by a plaque assay. For comparison, the infected mice were treated with 25 mg/kg of NITD008, and the reduction of peak viremia is presented.